Total Payments
$18,587
2024 Payments
$41.72
Companies
16
Transactions
151
Medicare Patients
8,493
Medicare Billing
$716,019
Payment Breakdown by Category
Other$13,000 (69.9%)
Travel$2,793 (15.0%)
Food & Beverage$2,686 (14.5%)
Education$106.97 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,000 | 6 | 69.9% |
| Travel and Lodging | $2,793 | 8 | 15.0% |
| Food and Beverage | $2,686 | 134 | 14.5% |
| Education | $106.97 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $16,592 | 47 | $0 (2023) |
| Astellas Pharma US Inc | $683.26 | 38 | $0 (2024) |
| UROVANT SCIENCES INC | $313.92 | 14 | $0 (2022) |
| Endo Pharmaceuticals Inc. | $227.29 | 9 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $146.52 | 8 | $0 (2023) |
| 180 Medical, Inc. | $91.18 | 5 | $0 (2020) |
| Tolmar, Inc. | $91.05 | 5 | $0 (2024) |
| Boston Scientific Corporation | $88.40 | 5 | $0 (2019) |
| Wilmington Medical Supply, Inc. | $83.36 | 3 | $0 (2017) |
| PFIZER INC. | $67.00 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.72 | 2 | Tolmar, Inc. ($27.26) |
| 2023 | $386.97 | 21 | Sumitomo Pharma America, Inc. ($146.52) |
| 2022 | $445.79 | 22 | UROVANT SCIENCES INC ($287.77) |
| 2021 | $103.51 | 5 | AbbVie Inc. ($36.16) |
| 2020 | $55.22 | 3 | Astellas Pharma US Inc ($35.44) |
| 2019 | $336.32 | 19 | Astellas Pharma US Inc ($92.03) |
| 2018 | $503.81 | 29 | Astellas Pharma US Inc ($259.51) |
| 2017 | $16,713 | 50 | AbbVie, Inc. ($16,310) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2024 | Tolmar, Inc. | JATENZO (Drug), ELIGARD | Food and Beverage | Cash or cash equivalent | $27.26 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 01/11/2024 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Urology | ||||||
| 11/08/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Urology | ||||||
| 11/01/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Urology | ||||||
| 10/27/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 09/13/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Prostate Cancer | ||||||
| 08/18/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Urology | ||||||
| 07/26/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Urology | ||||||
| 07/07/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Urology | ||||||
| 06/23/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/02/2023 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 05/10/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/25/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Urology | ||||||
| 04/22/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Urology | ||||||
| 03/29/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/22/2023 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/16/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Urology | ||||||
| 02/09/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Urology | ||||||
| 02/08/2023 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Prostate Cancer | ||||||
| 02/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: Urology | ||||||
| 02/02/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Urology | ||||||
| 01/24/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Urology | ||||||
| 01/03/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Urology | ||||||
| 12/14/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Urology | ||||||
| 11/30/2022 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 372 | 9,574 | $123,317 | $36,751 |
| 2022 | 15 | 2,227 | 52,541 | $505,323 | $164,890 |
| 2021 | 21 | 2,920 | 77,251 | $825,451 | $278,917 |
| 2020 | 19 | 2,974 | 74,740 | $818,245 | $235,462 |
Total Patients
8,493
Total Services
214,106
Medicare Billing
$716,019
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 205 | $42,230 | $13,336 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 115 | $34,960 | $10,869 | 31.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 50 | 54 | $31,320 | $9,730 | 31.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $4,860 | $1,535 | 31.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 60 | $4,380 | $662.40 | 15.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 86 | 118 | $1,062 | $402.38 | 37.9% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 11 | 9,010 | $4,505 | $215.43 | 4.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 562 | 1,181 | $169,998 | $67,775 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 373 | 484 | $89,218 | $37,584 | 42.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 110 | 121 | $55,705 | $23,048 | 41.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 15 | 97 | $89,751 | $13,981 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 75 | 75 | $21,864 | $8,575 | 39.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 117 | 382 | $22,018 | $4,229 | 19.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 317 | 450 | $26,100 | $3,091 | 11.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 509 | 862 | $10,344 | $1,926 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $3,872 | $1,759 | 45.4% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2022 | 23 | 48,686 | $10,822 | $1,004 | 9.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 14 | 15 | $1,500 | $850.43 | 56.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2022 | 11 | 12 | $2,820 | $762.16 | 27.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 52 | 58 | $522.00 | $197.78 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 27 | $204.50 | $77.31 | 37.8% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 76 | $584.00 | $30.35 | 5.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 725 | 1,797 | $242,352 | $109,688 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 543 | 763 | $132,802 | $66,192 | 49.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2021 | 25 | 238 | $232,050 | $34,411 | 14.8% |
About Dr. Kevin Geib, MD
Dr. Kevin Geib, MD is a Urology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871529958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Geib, MD has received a total of $18,587 in payments from pharmaceutical and medical device companies, with $41.72 received in 2024. These payments were reported across 151 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,000).
As a Medicare-enrolled provider, Geib has provided services to 8,493 Medicare beneficiaries, totaling 214,106 services with total Medicare billing of $716,019. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Winchester, VA
- Active Since 06/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1871529958
Products in Payments
- Androgel (Drug) $16,326
- GEMTESA (Drug) $460.44
- Myrbetriq (Drug) $249.25
- MYRBETRIQ (Drug) $221.53
- LUPRON DEPOT (Drug) $173.30
- XIAFLEX (Biological) $150.05
- XTANDI (Drug) $92.15
- ELIGARD (Drug) $85.80
- REZUM (Device) $75.29
- JATENZO (Drug) $62.18
- AVEED (Biological) $62.15
- SPEEDICATH (Device) $61.18
- Lupron (Drug) $54.82
- TOVIAZ (Drug) $52.37
- Erleada (Drug) $48.46
- Lupron Depot (Drug) $37.28
- Noctiva (Drug) $29.00
- Xtandi (Drug) $28.40
- Natesto (Drug) $25.46
- Otrexup (Drug) $24.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Winchester
Dr. Megan Bing, Md, MD
Urology — Payments: $9,721
Urology $9,721
Dr. Freddie Terrell, Md, MD
Urology — Payments: $4,379
Urology $4,379
Dr. Michael Hoffman, Md, MD
Urology — Payments: $2,172
Urology $2,172
Dr. Mark Levinson, M.d, M.D
Urology — Payments: $1,981
Urology $1,981
Michael Strickland, Do, DO
Urology — Payments: $1,723
Urology $1,723
Dr. John Warner, M.d, M.D
Urology — Payments: $1,434
Urology $1,434